List of insiders holdings for KINETA INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | PERRIGO SCIENCE ONE LTD. PERRIGO CORP LTD. ELAN PHARMA INTERNATIONAL LTD. PERRIGO HOLDINGS LTD. PERRIGO Co plc 10% Owner |
2017-02-13 16:15:48 | 2,908,067 0 |
2,908,067 | Form 13G |
2 | Novartis Bioventures Ltd NOVARTIS AG 10% Owner |
2019-02-05 16:07:14 | 1,356,541 0 |
1,356,541 | Form 13G |
3 | Susan L. Lindquist Family Trust Susan L. Lindquist Exempt Marital Trust Susan L. Lindquist Massachusetts Non-Exempt Marital Trust Susan L. Lindquist Massachusetts Only Marital Trust 10% Owner |
2021-01-04 16:39:59 | 0 1,190,599 |
1,190,599 | Form 3 |
4 | Chhabra Meenu President and CEO |
2020-03-04 17:04:07 | 406,800 0 |
406,800 | Form 4 |
5 | Guillaudeux Thierry Chief Scientific Officer |
2024-04-16 16:59:11 | 225,000 0 |
225,000 | Form 4 |
6 | Baker Keith Chief Financial Officer |
2024-04-16 17:01:08 | 225,000 0 |
225,000 | Form 4 |
7 | PHILIPS CRAIG W. President and Secretary |
2024-04-16 17:02:25 | 225,000 0 |
225,000 | Form 4 |
8 | FMR LLC See Remark 1 |
2023-02-10 09:08:41 | 220,707 0 |
220,707 | Form 13G |
9 | Wilson Sheila Chief Operating Officer |
2020-03-04 17:06:52 | 145,800 0 |
145,800 | Form 4 |
10 | Lee Po Shun See Remarks |
2019-03-05 16:40:14 | 142,900 0 |
142,900 | Form 4 |
11 | Gilmartin Geoffrey S. Chief Medical Officer |
2020-03-04 17:04:49 | 140,100 0 |
140,100 | Form 4 |
12 | Munoz Benito Chief Scientific Officer |
2020-03-04 17:06:14 | 132,500 0 |
132,500 | Form 4 |
13 | DETORE JAMES M. See Remarks |
2016-08-08 19:50:09 | 125,000 0 |
125,000 | Form 4 |
14 | Zecevic Marija Chief Commercial Officer |
2020-03-04 17:07:24 | 118,600 0 |
118,600 | Form 4 |
15 | COLES N ANTHONY Executive Chair |
2021-04-02 18:05:27 | 78,650 0 |
78,650 | Form 4 |
16 | Boudreau Helen M Chief Financial Officer |
2018-03-05 17:31:19 | 78,000 0 |
78,000 | Form 4 |
17 | Mohsen Paulash Chief Business Officer |
2022-02-07 16:05:20 | 59,135 0 |
59,135 | Form 4 |
18 | Rabinowitz Eric Director |
2018-06-19 16:09:20 | 45,900 0 |
45,900 | Form 4 |
19 | WALSH CHRISTOPHER T PHD Director |
2016-02-12 19:21:14 | 45,760 0 |
45,760 | Form 4 |
20 | Walshe Conor M Director |
2016-02-12 19:21:36 | 45,760 0 |
45,760 | Form 4 |
21 | Smart Janet L See Remarks |
2016-02-12 19:25:39 | 34,636 0 |
34,636 | Form 4 |
22 | Verma Ajay EVP, Head of R&D |
2021-12-03 16:15:58 | 30,000 200 |
30,200 | Form 4 |
23 | Robertson Brigitte Chief Medical Officer |
2021-02-03 18:39:54 | 25,064 0 |
25,064 | Form 4 |
24 | Hagen Brett R See Remarks |
2017-04-05 16:37:52 | 21,100 0 |
21,100 | Form 4 |
25 | Kenny Pauline General Counsel & Secretary |
2023-09-21 16:57:46 | 18,448 0 |
18,448 | Form 4 |
26 | BERGER FRANKLIN M Director |
2020-07-01 17:50:17 | 17,400 0 |
17,400 | Form 4 |
27 | Chowdhury Badrul A. Director |
2020-07-01 17:29:23 | 17,400 0 |
17,400 | Form 4 |
28 | Dulac Emmanuel Director |
2020-07-01 17:25:48 | 17,400 0 |
17,400 | Form 4 |
29 | BARRETT M JAMES Director 10% Owner |
2018-06-19 16:24:50 | 15,300 0 |
15,300 | Form 4 |
30 | PICKETT CECIL B Director |
2021-06-04 16:05:13 | 14,800 0 |
14,800 | Form 4 |
31 | Allen Patricia L Director |
2021-06-04 16:05:20 | 14,800 0 |
14,800 | Form 4 |
32 | Zydowsky Lynne Director |
2021-06-04 16:05:16 | 14,800 0 |
14,800 | Form 4 |
33 | Heyman Richard A. Director |
2021-06-04 16:05:27 | 14,800 0 |
14,800 | Form 4 |
34 | Kelly Jeffery W. Director |
2021-06-04 16:05:36 | 14,800 0 |
14,800 | Form 4 |
35 | Larson Eric D See Remarks |
2020-03-04 17:05:27 | 14,500 0 |
14,500 | Form 4 |
36 | Wyzga Michael D See Remarks |
2022-12-06 16:55:32 | 13,997 0 |
13,997 | Form 4 |
37 | Smith Devin Whittemore SVP and General Counsel |
2022-12-06 16:51:28 | 13,961 0 |
13,961 | Form 4 |
38 | Iadonato Shawn Director |
2024-09-05 16:21:14 | 12,500 0 |
12,500 | Form 4 |
39 | Bartoszek Raymond J. Director |
2024-09-05 16:19:07 | 12,500 0 |
12,500 | Form 4 |
40 | Arkowitz David Director |
2024-09-05 16:18:34 | 12,500 0 |
12,500 | Form 4 |
41 | Dylla Scott J. Director |
2024-09-05 16:20:19 | 12,500 0 |
12,500 | Form 4 |
42 | Peters Richard Director |
2024-09-05 16:21:48 | 12,500 0 |
12,500 | Form 4 |
43 | Foote Marion R Director |
2024-09-05 16:20:49 | 12,500 0 |
12,500 | Form 4 |
44 | Drapkin Kimberlee C Director |
2024-09-05 16:19:48 | 12,500 0 |
12,500 | Form 4 |
45 | Epstein Marie Principal Accounting Officer |
2022-12-06 16:52:58 | 8,883 0 |
8,883 | Form 4 |
46 | Mirzac Romeo Principal Accounting Officer |
2016-02-12 19:19:45 | 7,907 0 |
7,907 | Form 4 |
47 | Mirabelli Christopher HealthCare Ventures VIII L.P. CAVANAUGH JAMES H HealthCare Partners VIII LLC HealthCare Partners VIII L.P. LAWLOR AUGUSTINE LITTLECHILD JOHN W WERNER HAROLD R Director 10% Owner |
2017-03-10 12:46:09 | 3,813 0 |
3,813 | Form 13G |
48 | Alfieri Michael Interim Head of Finance |
2020-05-15 16:48:50 | 0 0 |
0 | Form 3 |
49 | New Enterprise Associates 12 Limited Partnership NEA Partners 12 Limited Partnership NEA 12 GP LLC BARRIS PETER J BASKETT FOREST KERINS PATRICK J SANDELL SCOTT D 10% Owner |
2019-12-06 13:02:36 | 0 0 |
0 | Form 13D |
50 | Zimmerman Sandra M. See Remarks |
2018-08-10 16:21:00 | 0 0 |
0 | Form 3 |
51 | Cormorant Asset Management LLC Chen Bihua Cormorant Global Healthcare GP LLC Cormorant Global Healthcare Master Fund LP 10% Owner |
2019-02-14 16:02:04 | 0 0 |
0 | Form 13G |
52 | New Enterprise Associates 12 Limited Partnership NEA Partners 12 Limited Partnership NEA 12 GP LLC BARRIS PETER J BASKETT FOREST KERINS PATRICK J KOLLURI KRISHNA KITTU SANDELL SCOTT D 10% Owner |
2019-12-06 13:02:36 | 0 0 |
0 | Form 13D |
53 | THIBAULT LANCE E See Remarks |
2016-02-10 20:37:58 | 0 0 |
0 | Form 3 |